APP Pharmaceuticals, Inc. Watch

from 10-K 185 pages Credit Agreement Dated as of November 13, 2007 Among APP Pharmaceuticals, Inc., App Pharmaceuticals, LLC, as the U.S. Borrower, Abraxis Bioscience Manufacturing, LLC, (To Be Renamed App Pharmaceuticals Manufacturing, LLC), as the P.R. Borrower, Deutsche Bank AG New York Branch, as Administrative Agent, Swing Line Lender and an L/C Issuer, the Other Lenders Party Hereto, and Deutsche Bank Securities Inc. and Wachovia Capital Markets, LLC, as Joint Lead Arrangers and as Joint Bookrunners

from 10-Q 79 pages Credit Agreement Among American Pharmaceutical Partners, Inc., to Become Known as Abraxis Bioscience, Inc., Various Lenders From Time to Time Party Hereto Fifth Third Bank, an Ohio Banking Corporation, as Agent and L/C Issuer, and Wachovia Bank, National Association, as Documentation Agent, and Harris Nesbitt Financing, Inc., as Syndication Agent Dated as of April 18, 2006 Fifth Third Bank, an Ohio Banking Corporation, as Bookrunner and Lead Arranger

from 8-K 8 pages American Pharmaceutical Partners, Inc. Total Commitment Increase Agreement and First Amendment to Credit Agreement

from 8-K 91 pages Credit Agreement Among American Pharmaceutical Partners, Inc. Various Lenders From Time to Time Party Hereto

from 10-K >50 pages Credit Agreement, Dated as of December 14, 2001